03/13/2026
Over the past several decades, survival rates for many blood cancers have improved dramatically. Thanks to ongoing advancements in research, we’ve seen major breakthroughs in early and more accurate diagnostics, targeted and personalized treatments, immunotherapies, and improved supportive care. These innovations are helping more people not only survive, but live longer, fuller, and more meaningful lives after a diagnosis.
But progress doesn’t happen by chance. Every new treatment, every clinical trial, and every improvement in care is made possible through sustained investment in research.
At the Leukemia & Lymphoma Society of Canada, we remain committed to funding life-saving research and accelerating innovation so that one day, blood cancers can be cured — and no one has to face this journey alone.
Learn more about how research is driving progress and how you can be part of it at www.bloodcancers.ca